A stroke guideline update is easy to skim and easy to misread. The headline points get quoted in a lecture, the nuance evaporates, and six months later a resident is confidently doing the thing the guideline actually stopped recommending. The 2026 AHA/ASA guideline for the early management of acute ischemic stroke is worth reading slowly, because several of its changes are less about new tools than about being more honest with the ones we already have.1 Here is the bedside version — what actually changes on your next shift, and why.

Tenecteplase joins the front line

The most practice-shaping line is also the least dramatic: within the 4.5-hour window, either alteplase or tenecteplase is now an endorsed choice.1 For anyone who has watched a code stroke, the appeal of tenecteplase is obvious — a single bolus instead of an hour-long infusion, which is simpler to give and easier to move a patient with. Years of trials showing it holds its own against alteplase have finally accumulated into a guideline that treats them as genuine alternatives rather than treating one as experimental.

The corollary matters just as much. For patients with clearly disabling deficits, the guideline supports rapid thrombolysis regardless of the NIHSS number — a useful corrective to the habit of talking oneself out of treating a low-scoring but genuinely disabling deficit, such as isolated aphasia or a hand that will end a career. Conversely, for genuinely non-disabling deficits, dual antiplatelet therapy is preferred over lytics. The score informs the conversation; the disability drives the decision.

The clock gets a little more forgiving

The rigid 4.5-hour wall softens for selected patients. For stroke of unknown onset — the classic wake-up stroke — or presentations 4.5 to 9 hours out, thrombolysis is supported when advanced imaging shows the right pattern: a diffusion or perfusion mismatch that says salvageable tissue is still on the table.1 This is the guideline catching up to what many comprehensive centers were already doing, and it reframes the question from "what time is it?" to "what does the tissue look like?"

Bedside pearl

Extended-window treatment is an imaging decision, not a stopwatch decision. If your center can get fast MRI or CT perfusion, the wake-up stroke you would once have waved off may now be a treatable one. Know your own door-to-imaging pathway before you need it at 3 a.m.

Thrombectomy keeps expanding

The endovascular envelope widens again. The guideline extends thrombectomy toward patients with larger ischemic cores — the group we used to exclude on the assumption there was too little to save — following the recent large-core trials.1 And basilar artery occlusion, long treated in a haze of uncertainty, now gets a strong recommendation for thrombectomy within 24 hours in patients with an NIHSS of 10 or more. For posterior-circulation strokes, that is a real change in tone: from "consider" to "do."

Two reflexes to unlearn

The most instructive updates are the ones that tell us to do less. First, blood pressure: intensive systolic lowering to below 140 mmHg is not recommended, even after complete reperfusion. Pushing pressure down hard does not improve functional outcomes after intravenous thrombolysis and may cause harm after thrombectomy.1 The instinct to normalize the number on the monitor is exactly the instinct to resist.

Second, glucose: intensive control to a tight 80–130 mg/dL range is not recommended, because it does not improve outcomes and it buys real hypoglycemia risk.1 Treat the dangerous extremes, avoid the sliding-scale theater. Both changes share a theme — a decade of trials teaching us that tidy numbers are not the same as better brains.

Children get a guideline of their own

For the first time, the document includes recommendations for pediatric stroke — a population that has spent years borrowing adult protocols by necessity.1 The emphasis is on early recognition (childhood stroke is still routinely missed or delayed) and on the safety and potential benefit of thrombectomy in selected children. It will not change most adult-medicine shifts, but for pediatric emergency and neurology teams it is a landmark: the first time the guidance was written with their patients specifically in mind.

Care moves upstream

Finally, the systems-of-care story continues its march out of the hospital. Mobile stroke units — ambulances carrying a CT scanner and the ability to start treatment at the curb — earn formal recommendation on the strength of outcome data, and the guideline reinforces expanded access to clot-removal procedures.1 The through-line of the last decade holds: the biggest gains in stroke care keep coming from shortening the distance between symptom and treatment, not just from new drugs.

What to take to your next shift

If you remember three things: tenecteplase is a first-class option and the disabling-deficit patient gets treated regardless of a low NIHSS; the extended window is an imaging call, not a clock call; and the reflex to crush blood pressure and glucose is the reflex to drop. The rest is refinement of a direction stroke care has held for years — treat more people, faster, and stop chasing numbers that never changed outcomes. As always, this is an educational summary; the full guideline is the source of truth, and local protocols and individual judgment still govern the patient in front of you.1